[Selection of therapeutic procedures according to the clinicopathological features of breast cancer].
The therapeutic guidelines for breast cancer do not depend on histological type, by which prognosis can differ according to minor variations. Treatment for breast cancer is subdivided into two categories; one is for primary breast cancer which is curable by surgery and the other is for advanced or recurrent breast cancer. In the former category, the surgical method and adjuvant therapy are selected according to stage. In the latter, endocrine therapy, chemotherapy, immunotherapy and radiotherapy are indicated in single or combined use. Main factors of selection in such cases are menopausal status, estrogen receptor status and site of distant metastasis.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000031:analogs & derivatives; D017258:Medroxyprogesterone Acetate; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D011960:Receptors, Estrogen / Q000032:analysis; D013629:Tamoxifen / Q000008:administration & dosage
D011960:Receptors, Estrogen; D013629:Tamoxifen; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone